NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis announced it has received a €2.5 million ($2.7 million) grant from the Flemish Agency for Innovation & Entrepreneurship (IWT) to expand its manufacturing capacity.

The award comes under the agency's Strategic Transformation Support program and will be used to support manufacturing of the firm's PCR-based Idylla diagnostic platform and assays. Funds will also be used to support training and education for workers at its Mechelen, Belgium facility.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.